Arcadia Biosciences, Inc.

8-K Director or officer change; Item 5.08; Other events Jul 2, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jun 15, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Changed accountants Apr 3, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Results of operations (earnings release) Mar 26, 2026 8-K Director or officer change Feb 6, 2026 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Regulation FD disclosure Jan 14, 2026 8-K Terminated a material agreement; Regulation FD disclosure Dec 29, 2025 8-K Shareholder vote results Dec 23, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Results of operations (earnings release) Nov 7, 2025 8-K Item 5.08; Other events Oct 24, 2025 8-K Director or officer change Aug 29, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Regulation FD disclosure; Other events May 16, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Entered a material agreement May 2, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 8-K Entered a material agreement Apr 3, 2025 10-K Fiscal year ended 2024-12-31 Mar 25, 2025 8-K Results of operations (earnings release) Mar 20, 2025 8-K Regulation FD disclosure Dec 11, 2024 8-K Entered a material agreement; Change in control; Director or officer change; Regulation FD disclosure Dec 6, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K/A Director or officer change Aug 23, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Director or officer change Aug 7, 2024 8-K Director or officer change Jul 8, 2024 8-K Shareholder vote results Jul 1, 2024 8-K Entered a material agreement; Completed an acquisition or disposition May 20, 2024 8-K Entered a material agreement; Completed an acquisition or disposition May 17, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Results of operations (earnings release) May 9, 2024